Added to YB: 2025-12-18
Pitch date: 2025-12-15
PFE [bullish]
Pfizer Inc.
+7.02%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
Market Cap
$161.1B
Pitch Price
$26.00
Price Target
N/A
Dividend
6.07%
EV/EBITDA
8.09
P/E
20.82
EV/Sales
3.44
Sector
Pharmaceuticals
Category
value
Show full summary:
Rotating Out of Winners Into Higher Asymmetry: Why We’re Buying a Healthcare Basket - Pfizer Inc.
PFE: Post-COVID reset priced in. Trading 8.5x P/E, 6.6-6.9% dividend yield. $7.2B cost savings by 2027 ($4.5B by YE25), FY25 EPS guidance raised to $3.00-$3.15. Operating leverage at single-digit multiple. Catalysts: cost-save progress, portfolio pruning, oncology/immunology readouts.
Read full article (1 min)